The new artificial intelligence-based software and robot-assisted biopsy technology helps providers catch and treat lung cancer in its earliest stages.

Tal Parnes, Chairman of the Board of Inspira Technologies, stated: “The contemplated acquisition of this liquid biopsy platform represents a significant value inflection point for Inspira, adding a ...

Noon, Chief Executive Officer of Inspira, commented “We are positioning the Company to expand into a high-growth diagnostics market through the planned acquisition of a development-ready liquid biopsy ...

Official websites use .mil A .mil website belongs to an official U.S. Department of Defense organization in the United States ...

Cancer is most treatable in its early stages, so finding innovative and non-invasive methods to diagnose cancer early on is crucial for fighting the disease. Liquid biopsies, which require just a ...

Investing.com -- Inspira Technologies OXY B.H.N. Ltd (NASDAQ:IINN) stock gained 5.1% in Thursday premarket trading after the company outlined its strategic framework for expanding into liquid biopsy ...

Cancer care is becoming more targeted with the development of therapies that address specific genetic signatures. Before such drugs are used, a test identifies whether a patient’s cancer matches an ...

Shares of Inspira Technologies OXY B.H.N. Ltd (NASDAQ:IINN) rose 5.1% in premarket trading on Thursday after the company set out a strategic roadmap to expand into liquid biopsy diagnostics while ...

Goal to improve patient outcomes through early, accurate detection of residual or recurring cancer Haystack's highly sensitive minimal-residual disease cancer-detection technology to be combined with ...

Inspira Technologies Oxy BHN ( ($IINN) ) has issued an announcement. On January 5, 2026, Inspira Technologies Oxy B.H.N. Ltd. signed a non-binding ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Body Vision Medical, a leader in AI-driven, intraoperative image guidance, today announced that its LungVision® system has been selected as the winner of the “Best ...

Often regarded in oncology as a complementary diagnostic or early detection tool, liquid biopsy has moved into routine clinical use to help guide treatment decisions in the era of targeted, ...